<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM "BioC.dtd"><collection><source>mturk k=16</source><date></date><key></key><document><id>3464560</id><infon key="annotator_ids">[1292, 1293, 1004, 1290, 1291, 1296, 683, 1319, 1297, 1318, 1294, 1317, 1295, 1316, 1315, 1314, 1313, 1310, 1098, 152, 748, 1289, 1288, 1287, 678, 1280, 1282, 1283, 1284, 1285, 1286, 1321, 1088, 936, 1320, 1087, 938, 1322, 737, 543, 876, 1276, 1279, 874, 1278, 731, 1274, 1275, 1273, 1270, 1271, 18, 727, 518, 1269, 1267, 1265, 1307, 1261, 1306, 1262, 1309, 813, 1263, 1308, 698, 1260, 818, 914, 1301, 1300, 1303, 1302, 1061, 1304, 716, 993, 1259, 1258, 618, 1255, 1254, 1257, 1256, 194, 1253, 1252, 984, 1251, 1250, 1245, 1246, 1243, 1249, 1247, 385, 703, 704, 702, 637, 633, 838, 1035, 634, 1240, 501, 1038, 1242, 1232, 1234, 1235, 1236, 1237, 1239, 766, 1231, 1230, 1227, 1228, 1225, 1226, 1223, 1224, 1221, 1222, 959, 752, 658, 750, 751, 1298, 1299, 652, 1220, 1215, 1216, 1217, 1210, 1211, 1213, 565, 1218, 1219, 1209]</infon><infon key="n_annotators">144</infon><passage><infon key="type">title</infon><offset>0</offset><text>Estimation of the male to female ratio of mutation rates from the segregation of X-chromosomal DNA haplotypes in Duchenne muscular dystrophy families.  </text><annotation id="178012"><infon key="annotator_ids">[1004, 543, 565, 703, 634, 1210, 704, 618, 838, 936, 1211, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1219, 1220, 984, 678, 1221, 1222, 1223, 194, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1231, 1218, 938, 1234, 1235, 876, 1236, 1237, 813, 1239, 1240, 385, 1242, 1243, 1038, 1246, 1061, 1247, 1250, 1249, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1274, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1283, 1284, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1294, 1295, 1297, 1298, 702, 1299, 1300, 750, 1302, 1304, 1303, 1306, 1307, 1308, 1309, 1310, 698, 959, 1313, 1314, 1315, 1316, 1318, 731, 1319, 637, 716, 1321, 1098, 1322]</infon><infon key="n_annotators">127</infon><infon key="type">Disease</infon><location offset="113" length="27"/><text>Duchenne muscular dystrophy</text></annotation></passage><passage><infon key="type">abstract</infon><offset>152</offset><text>A novel procedure is presented to estimate the ratio of male to female mutation rates for Duchenne muscular dystrophy ( DMD ) . X-specific restriction fragment length polymorphisms are used to establish DNA haplotypes in three-generation DMD families . From the proportion of DMD patients who have inherited their maternal grandfathers X chromosome , the ratio of mutation rates can be calculated . In contrast to classical methods , the proposed procedure is not restricted to sporadic or familiar cases nor is any information on the carrier status of female relatives required . . </text><annotation id="184031"><infon key="annotator_ids">[1224, 1087, 1232, 658, 1245, 1246, 633, 1271, 1275, 1282, 1285, 1287, 1293, 1296, 1300, 1301, 1317]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="242" length="8"/><text>Duchenne</text></annotation><annotation id="177965"><infon key="annotator_ids">[874, 1209, 543, 565, 703, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1219, 1220, 984, 678, 1221, 1223, 194, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1231, 1218, 938, 1234, 1235, 876, 1236, 1237, 813, 1239, 1240, 385, 1242, 1243, 1038, 1061, 1247, 1250, 1249, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 752, 1276, 1278, 1279, 727, 1280, 1283, 1284, 1287, 1289, 1290, 1291, 818, 1292, 1295, 1297, 1298, 1299, 750, 1302, 1304, 1303, 1306, 1307, 1308, 1310, 698, 959, 1313, 1314, 1316, 1318, 731, 637, 716, 1320, 1321, 1322]</infon><infon key="n_annotators">116</infon><infon key="type">Disease</infon><location offset="242" length="27"/><text>Duchenne muscular dystrophy</text></annotation><annotation id="177964"><infon key="annotator_ids">[874, 1004, 1209, 543, 565, 703, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1219, 1220, 984, 678, 1221, 1223, 1224, 194, 1088, 1225, 993, 1226, 1227, 1228, 1087, 1230, 1231, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1247, 1250, 1249, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 633, 1269, 1270, 1261, 737, 748, 1271, 1273, 1274, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1289, 1290, 1291, 818, 1292, 1293, 1295, 1296, 1297, 1298, 1299, 1300, 750, 1301, 1302, 1304, 1303, 1306, 1307, 1308, 1310, 698, 959, 1313, 1314, 1317, 1318, 731, 637, 716, 1320, 1321, 1098, 1322]</infon><infon key="n_annotators">135</infon><infon key="type">Disease</infon><location offset="272" length="3"/><text>DMD</text></annotation><annotation id="177966"><infon key="annotator_ids">[874, 1004, 543, 565, 703, 634, 1210, 704, 838, 936, 501, 1213, 1215, 1035, 18, 1219, 1220, 984, 678, 1221, 1222, 1224, 194, 1088, 1225, 993, 1226, 1227, 1228, 1087, 1230, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1247, 1249, 751, 1251, 1252, 652, 1253, 1255, 1256, 1258, 1259, 152, 914, 1262, 1263, 518, 1265, 633, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1301, 1302, 1304, 1303, 1306, 1307, 1308, 1309, 698, 959, 1313, 1314, 1315, 1317, 1318, 731, 1319, 637, 716, 1320, 1321, 1098, 1322]</infon><infon key="n_annotators">127</infon><infon key="type">Disease</infon><location offset="390" length="3"/><text>DMD</text></annotation><annotation id="177967"><infon key="annotator_ids">[874, 1004, 1209, 543, 565, 703, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1217, 1035, 18, 1219, 1220, 984, 678, 1221, 1222, 1224, 194, 1088, 1225, 993, 1226, 1227, 1228, 1087, 1230, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1247, 1250, 1249, 751, 1251, 1252, 652, 1253, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 633, 1269, 1270, 1261, 737, 748, 1271, 1273, 1274, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 1299, 1300, 750, 1301, 1302, 1303, 1306, 1307, 1308, 698, 959, 1313, 1314, 1315, 1317, 1318, 731, 1319, 637, 716, 1320, 1321, 1098, 1322]</infon><infon key="n_annotators">131</infon><infon key="type">Disease</infon><location offset="428" length="3"/><text>DMD</text></annotation></passage></document><document><id>10554035</id><infon key="annotator_ids">[1293, 752, 658, 683, 1270, 1294, 1035, 838, 652, 634, 1088, 1252, 1310, 727, 1223, 876]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization.  </text></passage><passage><infon key="type">abstract</infon><offset>119</offset><text>von Hippel-Lindau ( VHL ) disease is an autosomal dominantly inherited cancer syndrome predisposing to a variety of tumor types that include retinal hemangioblastomas , hemangioblastomas of the central nervous system , renal cell carcinomas , pancreatic cysts and tumors , pheochromocytomas , endolymphatic sac tumors , and epididymal cystadenomas [ W . M . Linehan et al . , J . Am . Med . Assoc . , 273  564-570 , 1995 ; E . A . Maher and W . G . Kaelin , Jr . , Medicine ( Baltimore ) , 76  381-391 , 1997 ; W . M . Linehan and R . D . Klausner , In  B . Vogelstein and K . Kinzler ( eds . ) , The Genetic Basis of Human Cancer , pp . 455-473 , McGraw-Hill , 1998 ] . The VHL gene was localized to chromosome 3p25-26 and cloned [ F . Latif et al . , Science ( Washington DC ) , 260  1317-1320 , 1993 ] . Germline mutations in the VHL gene have been detected in the majority of VHL kindreds . The reported frequency of detection of VHL germline mutations has varied from 39 to 80 % ( J . M . Whaley et al . , Am . J . Hum . Genet . , 55  1092-1102 , 1994 ; Clinical Research Group for Japan , Hum . Mol . Genet . , 4  2233-2237 , 1995 ; F . Chen et al . , Hum . Mutat . , 5  66-75 , 1995 ; E . R . Maher et al . , J . Med . Genet . , 33  328-332 , 1996 ; B . Zbar , Cancer Surv . , 25  219-232 , 1995 ) . Recently a quantitative Southern blotting procedure was found to improve this frequency ( C . Stolle et al . , Hum . Mutat . , 12  417-423 , 1998 ) . In the present study , we report the use of fluorescence in situ hybridization ( FISH ) as a method to detect and characterize VHL germline deletions . We reexamined a group of VHL patients shown previously by single-strand conformation and sequencing analysis not to harbor point mutations in the VHL locus . We found constitutional deletions in 29 of 30 VHL patients in this group using cosmid and P1 probes that cover the VHL locus . We then tested six phenotypically normal offspring from four of these VHL families  two were found to carry the deletion and the other four were deletion-free . In addition , germline mosaicism of the VHL gene was identified in one family . In sum , FISH was found to be a simple and reliable method to detect VHL germline deletions and practically useful in cases where other methods of screening have failed to detect a VHL gene abnormality </text><annotation id="187716"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="260" length="25"/><text>retinal hemangioblastomas</text></annotation><annotation id="187721"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="392" length="17"/><text>pheochromocytomas</text></annotation><annotation id="187722"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="412" length="24"/><text>endolymphatic sac tumors</text></annotation><annotation id="187723"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="443" length="23"/><text>epididymal cystadenomas</text></annotation><annotation id="187728"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1703" length="3"/><text>VHL</text></annotation><annotation id="187730"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1874" length="3"/><text>VHL</text></annotation><annotation id="187731"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1932" length="3"/><text>VHL</text></annotation><annotation id="187732"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="2001" length="3"/><text>VHL</text></annotation><annotation id="187733"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="2083" length="3"/><text>VHL</text></annotation><annotation id="187734"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="2214" length="3"/><text>VHL</text></annotation><annotation id="187735"><infon key="annotator_ids">[658, 1223, 634, 1270, 727, 1293, 1310, 838, 752, 1294, 876, 1252, 652, 683, 1088, 1035]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="2323" length="3"/><text>VHL</text></annotation></passage></document><document><id>10447258</id><infon key="annotator_ids">[752, 658, 683, 838, 634, 18, 936, 1088, 1310, 152, 737, 1235, 727, 1217, 1236, 1223, 385, 876, 1218, 1254]</infon><infon key="n_annotators">20</infon><passage><infon key="type">title</infon><offset>0</offset><text>Identification of a common PEX1 mutation in Zellweger syndrome.  </text><annotation id="179721"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 1218, 1254, 1223, 18, 876, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="44" length="18"/><text>Zellweger syndrome</text></annotation></passage><passage><infon key="type">abstract</infon><offset>65</offset><text>The Zellweger spectrum of disease , encompassing Zellweger syndrome and the progressively milder phenotypes of neonatal adrenoleukodystrophy and infantile Refsum disease , is due to a failure to form functional peroxisomes . Cell fusion complementation studies demonstrated that these diseases are genetically heterogeneous , with two-thirds of all patients lying within a single complementation group , CG1 . Molecular genetic and cell biology studies have shown that PEX1 is deficient in many CG1 patients . However , previous studies have focused on mildly affected patients and there is still no report of two mutant PEX1 alleles in any Zellweger syndrome patient . Furthermore , mutations in the PMP70 gene have also been identified in two Zellweger syndrome patients from CG1 , raising the possibility that CG1 patients may represent a mixture of PEX1-deficient and PMP70-deficient individuals . To address the molecular basis of disease in Zellweger syndrome patients from CG1 , we examined all 24 PEX1 exons in four patients , including both patients that have mutations in PMP70 . PEX1 mutations were detected in all four patients , including a 1-bp insertion ( c . 2097insT ) in exon 13 that was present in three of the four patients . Subsequent studies demonstrated that this mutation is present in one-half of all CG1 patients and correlates with the Zellweger syndrome phenotype . As this mutation leads to a loss of protein function its frequency makes it the most common cause of Zellweger syndrome , helping to explain the high percentage of patients that belong to CG1 . </text><annotation id="179723"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 1088, 658, 936]</infon><infon key="n_annotators">19</infon><infon key="type">Disease</infon><location offset="114" length="18"/><text>Zellweger syndrome</text></annotation><annotation id="179724"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 18, 737, 752, 727, 152, 1088, 658, 936]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="176" length="29"/><text>neonatal adrenoleukodystrophy</text></annotation><annotation id="179725"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 1218, 1254, 1223, 876, 18, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="210" length="24"/><text>infantile Refsum disease</text></annotation><annotation id="179727"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">20</infon><infon key="type">Disease</infon><location offset="706" length="18"/><text>Zellweger syndrome</text></annotation><annotation id="179728"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">20</infon><infon key="type">Disease</infon><location offset="810" length="18"/><text>Zellweger syndrome</text></annotation><annotation id="179729"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">20</infon><infon key="type">Disease</infon><location offset="1012" length="18"/><text>Zellweger syndrome</text></annotation><annotation id="179730"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">20</infon><infon key="type">Disease</infon><location offset="1429" length="18"/><text>Zellweger syndrome</text></annotation><annotation id="179731"><infon key="annotator_ids">[634, 1217, 1236, 838, 683, 385, 1218, 1254, 1223, 876, 1235, 18, 737, 752, 727, 1310, 152, 1088, 658, 936]</infon><infon key="n_annotators">20</infon><infon key="type">Disease</infon><location offset="1561" length="18"/><text>Zellweger syndrome</text></annotation></passage></document><document><id>7550230</id><infon key="annotator_ids">[678, 1306, 1275, 1293, 752, 683, 1270, 634, 1220, 1252, 1310, 748, 727, 1224, 385, 703, 1279, 1254]</infon><infon key="n_annotators">18</infon><passage><infon key="type">title</infon><offset>0</offset><text>Three novel aniridia mutations in the human PAX6 gene.  </text></passage><passage><infon key="type">abstract</infon><offset>56</offset><text>Aniridia ( iris hypoplasia ) is an autosomal dominant congenital disorder of the eye . Mutations in the human aniridia ( PAX6 ) gene have now been identified in many patients from various ethnic groups . In the study reported here we describe PAX6 mutations in one sporadic and five familial cases with aniridia . Of the four different mutations identified , one was identical to a previously reported mutation ( C-- > T transition at codon 240 ) , and three were novel  two in the glycine-rich region and one in the proline / serine / threonine-rich ( PST ) region . One PAX6 mutation found in the PST region was associated with cataracts in an aniridia family . Another splice mutation in the PST domain occurred in an aniridia patient with anosmia ( inability to smell ) . The six new aniridia cases reported here have mutations predicted to generate incomplete PAX6 proteins . These results support the theory that human aniridia is caused by haploinsufficiency of PAX6 . . </text><annotation id="182105"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 1310, 727, 683, 385, 1306]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="56" length="8"/><text>Aniridia</text></annotation><annotation id="182106"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 1310, 727, 683, 385, 1306]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="67" length="15"/><text>iris hypoplasia</text></annotation><annotation id="182108"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 727, 683, 385, 1306]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="359" length="8"/><text>aniridia</text></annotation><annotation id="204253"><infon key="annotator_ids">[748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 727, 683, 385, 1306]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="777" length="8"/><text>aniridia</text></annotation><annotation id="182110"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 1310, 727, 683, 385, 1306]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="799" length="7"/><text>anosmia</text></annotation><annotation id="182111"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 1270, 1310, 752, 727, 683, 385, 1306]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="809" length="18"/><text>inability to smell</text></annotation><annotation id="182112"><infon key="annotator_ids">[1220, 748, 1254, 678, 1275, 634, 1224, 703, 1279, 1293, 1252, 752, 1270, 1310, 727, 683, 385, 1306]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="844" length="8"/><text>aniridia</text></annotation></passage></document><document><id>10364520</id><infon key="annotator_ids">[1292, 1004, 1293, 1290, 1291, 1296, 683, 1319, 1297, 1318, 1294, 1295, 1316, 1315, 1314, 1313, 1310, 1098, 152, 748, 1289, 1288, 1287, 678, 1280, 1282, 1283, 1284, 1285, 1286, 1321, 936, 1088, 1320, 938, 737, 543, 876, 1276, 1279, 874, 1278, 1275, 1270, 1271, 18, 727, 518, 1269, 1267, 1307, 1261, 1306, 813, 1308, 698, 1260, 818, 914, 1300, 1303, 1302, 1061, 1304, 716, 1259, 1258, 618, 1255, 1254, 1257, 1256, 642, 194, 1253, 1252, 1251, 984, 1250, 1245, 1246, 1249, 385, 703, 704, 702, 637, 838, 1035, 634, 1240, 501, 1038, 1242, 1232, 1234, 1235, 1236, 1239, 766, 1231, 1230, 1227, 1228, 1225, 1226, 1223, 1224, 1221, 1222, 752, 658, 750, 751, 1298, 1299, 652, 1220, 1215, 1216, 1217, 1210, 1213, 565, 1218]</infon><infon key="n_annotators">125</infon><passage><infon key="type">title</infon><offset>0</offset><text>MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications.  </text><annotation id="177986"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1215, 1216, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1225, 1227, 1228, 1230, 1231, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">123</infon><infon key="type">Disease</infon><location offset="45" length="28"/><text>Familial Mediterranean fever</text></annotation></passage><passage><infon key="type">abstract</infon><offset>196</offset><text>Familial Mediterranean fever ( FMF ) is a recessively inherited disorder that is common in patients of Armenian ancestry . To date , its diagnosis , which can be made only retrospectively , is one of exclusion , based entirely on nonspecific clinical signs that result from serosal inflammation and that may lead to unnecessary surgery . Renal amyloidosis , prevented by colchicine , is the most severe complication of FMF , a disorder associated with mutations in the MEFV gene . To evaluate the diagnostic and prognostic value of MEFV-gene analysis , we investigated 90 Armenian FMF patients from 77 unrelated families that were not selected through genetic-linkage analysis . Eight mutations , one of which ( R408Q ) is new , were found to account for 93 % of the 163 independent FMF alleles , with both FMF alleles identified in 89 % of the patients . In several instances , family studies provided molecular evidence for pseudodominant transmission and incomplete penetrance of the disease phenotype . The M694V homozygous genotype was found to be associated with a higher prevalence of renal amyloidosis and arthritis , compared with other genotypes ( P = . 0002 and P = . 006 , respectively ) . The demonstration of both the diagnostic and prognostic value of MEFV analysis and particular modes of inheritance should lead to new ways for management of FMF-including genetic counseling and therapeutic decisions in affected families .</text><annotation id="177987"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1215, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1225, 1227, 1228, 1230, 1231, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1295, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">121</infon><infon key="type">Disease</infon><location offset="196" length="28"/><text>Familial Mediterranean fever</text></annotation><annotation id="177988"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1215, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1225, 1227, 1228, 1230, 1231, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1297, 1298, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">119</infon><infon key="type">Disease</infon><location offset="227" length="3"/><text>FMF</text></annotation><annotation id="178225"><infon key="annotator_ids">[565, 704, 838, 936, 501, 1216, 683, 18, 678, 1221, 1226, 1225, 1227, 1234, 1235, 658, 1242, 1038, 1061, 1252, 1254, 1256, 1259, 914, 1269, 727, 1282, 1285, 818, 1295, 1296, 1298, 1308, 642, 1321, 1098]</infon><infon key="n_annotators">36</infon><infon key="type">Disease</infon><location offset="238" length="30"/><text>recessively inherited disorder</text></annotation><annotation id="177994"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1215, 1216, 1217, 683, 678, 1222, 1223, 1224, 1088, 1226, 1227, 1231, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 385, 1242, 1038, 938, 1061, 1250, 1249, 751, 1251, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 1280, 1282, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1292, 1293, 1295, 1296, 1297, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1318, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">101</infon><infon key="type">Disease</infon><location offset="470" length="20"/><text>serosal inflammation</text></annotation><annotation id="177995"><infon key="annotator_ids">[874, 543, 565, 634, 704, 618, 838, 703, 501, 1215, 1216, 1217, 1035, 683, 18, 678, 1221, 1223, 1224, 1088, 1226, 1225, 1227, 1228, 1231, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">118</infon><infon key="type">Disease</infon><location offset="534" length="17"/><text>Renal amyloidosis</text></annotation><annotation id="177989"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1215, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1225, 1227, 1228, 1230, 1231, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">124</infon><infon key="type">Disease</infon><location offset="615" length="3"/><text>FMF</text></annotation><annotation id="177990"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 618, 838, 703, 936, 1215, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1227, 1228, 1230, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 385, 1242, 1038, 938, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 1267, 1269, 1270, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 698, 1313, 1314, 1315, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">113</infon><infon key="type">Disease</infon><location offset="777" length="3"/><text>FMF</text></annotation><annotation id="177991"><infon key="annotator_ids">[874, 543, 565, 634, 704, 618, 838, 703, 936, 501, 1215, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1227, 1228, 1230, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 752, 1276, 1278, 1279, 727, 766, 1280, 1284, 1285, 1286, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 750, 1304, 1303, 1302, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">114</infon><infon key="type">Disease</infon><location offset="979" length="3"/><text>FMF</text></annotation><annotation id="177992"><infon key="annotator_ids">[874, 543, 565, 634, 704, 618, 838, 703, 936, 501, 1216, 1217, 1035, 683, 18, 1220, 678, 1221, 1222, 1223, 1224, 1088, 1226, 1227, 1228, 1230, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 984, 1258, 1259, 152, 1260, 914, 1213, 1267, 1269, 1270, 1261, 737, 748, 1271, 1232, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1283, 1284, 1285, 1286, 1288, 1257, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 750, 1304, 1303, 1302, 1307, 1308, 1310, 642, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1098]</infon><infon key="n_annotators">114</infon><infon key="type">Disease</infon><location offset="1003" length="3"/><text>FMF</text></annotation><annotation id="177996"><infon key="annotator_ids">[874, 543, 565, 634, 618, 838, 703, 936, 501, 1215, 1216, 1217, 683, 18, 1220, 678, 1224, 1088, 1226, 1227, 1218, 1234, 876, 1236, 658, 813, 1240, 385, 1242, 1038, 1245, 1250, 1249, 751, 1252, 652, 1254, 1255, 984, 1258, 152, 1260, 1213, 518, 1267, 1269, 1270, 1261, 748, 1271, 1232, 1275, 1276, 1278, 727, 1280, 1283, 1284, 1285, 1287, 1288, 1257, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 750, 1304, 1303, 1302, 1307, 1308, 698, 1313, 1315, 1316, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">88</infon><infon key="type">Disease</infon><location offset="1288" length="17"/><text>renal amyloidosis</text></annotation><annotation id="177997"><infon key="annotator_ids">[874, 543, 565, 634, 618, 703, 936, 501, 1215, 1216, 1217, 683, 18, 1220, 678, 1224, 1088, 1226, 1227, 1218, 1234, 876, 1236, 658, 813, 1240, 385, 1242, 1038, 1245, 1250, 1249, 751, 1252, 652, 1254, 1255, 1256, 984, 1258, 152, 1260, 914, 1213, 518, 1267, 1269, 1270, 1261, 748, 1271, 1232, 1275, 1276, 1278, 727, 1280, 1283, 1284, 1285, 1287, 1288, 1257, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 750, 1304, 1303, 1302, 1307, 1308, 698, 1313, 1315, 1316, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">89</infon><infon key="type">Disease</infon><location offset="1310" length="9"/><text>arthritis</text></annotation><annotation id="177993"><infon key="annotator_ids">[874, 543, 565, 704, 618, 838, 703, 936, 1215, 1216, 683, 1220, 1224, 1228, 1230, 1231, 1218, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1061, 1250, 1249, 751, 1251, 1253, 1254, 1255, 984, 1258, 152, 1260, 1213, 1269, 1270, 1261, 748, 1271, 1232, 1275, 1276, 1278, 1279, 727, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1257, 1289, 818, 1292, 1295, 1296, 1297, 750, 1304, 1303, 1302, 1307, 1310, 642, 698, 1313, 1318, 1004, 1319, 1320]</infon><infon key="n_annotators">79</infon><infon key="type">Disease</infon><location offset="1555" length="13"/><text>FMF-including</text></annotation></passage></document><document><id>8198128</id><infon key="annotator_ids">[1292, 1004, 1293, 1290, 1291, 683, 1296, 1319, 1297, 1318, 1294, 1295, 1316, 1315, 1314, 1313, 1310, 1098, 152, 748, 1289, 1288, 1287, 678, 1280, 1282, 1283, 1284, 1285, 1286, 1321, 936, 1088, 1320, 938, 737, 543, 876, 1276, 1279, 874, 1278, 731, 1275, 1273, 1270, 1271, 18, 727, 518, 1269, 1267, 1265, 1261, 1307, 1262, 1306, 1263, 813, 1308, 698, 1260, 818, 914, 1300, 1303, 1061, 1302, 1304, 716, 993, 1259, 1258, 618, 1255, 1254, 1257, 1256, 642, 194, 1253, 1252, 1251, 984, 1250, 1245, 1246, 1249, 385, 703, 704, 702, 637, 838, 1035, 634, 1240, 501, 1038, 1242, 1232, 1234, 1235, 1236, 1239, 766, 1231, 1230, 1227, 1228, 1225, 1226, 1223, 1224, 1221, 1222, 752, 658, 750, 751, 1298, 1299, 652, 1220, 1215, 1216, 1217, 1210, 1213, 565, 1218]</infon><infon key="n_annotators">131</infon><passage><infon key="type">title</infon><offset>0</offset><text>Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval.  </text><annotation id="178138"><infon key="annotator_ids">[543, 634, 704, 618, 838, 703, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1231, 1232, 1218, 1234, 1235, 876, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1061, 1250, 1249, 194, 751, 1251, 1252, 1253, 1254, 1255, 1256, 1258, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 748, 1271, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1257, 1289, 1290, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 1299, 1304, 1302, 1306, 1307, 1308, 1310, 698, 1315, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">108</infon><infon key="type">Disease</infon><location offset="65" length="17"/><text>Friedreich ataxia</text></annotation></passage><passage><infon key="type">abstract</infon><offset>119</offset><text>The locus for Friedreich ataxia ( FRDA ) , a severe neurodegenerative disease , is tightly linked to markers D9S5 and D9S15 , and analysis of rare recombination events has suggested the order cen-FRDA-D9S5-D9S15-qter . We report here the construction of a YAC contig extending 800 kb centromeric to D9S5 and the isolation of five new microsatellite markers from this region . In order to map these markers with respect to the FRDA locus , all within a 1-cM confidence interval , we sought to increase the genetic information of available FRDA families by considering homozygosity by descent and association with founder haplotypes in isolated populations . This approach allowed us to identify one phase-known recombination and one probable historic recombination on haplotypes from Reunion Island patients , both of which place three of the five markers proximal to FRDA . This represents the first identification of close FRDA flanking markers on the centromeric side . The two other markers allowed us to narrow the breakpoint of a previously identified distal recombination that is > 180 kb from D9S5 ( 26P ) . Taken together , the results place the FRDA locus in a 450-kb interval , which is small enough for direct search of candidate genes . A detailed rare cutter restriction map and a cosmid contig covering this interval were constructed and should facilitate the search of genes in this region . . </text><annotation id="177978"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1231, 1232, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1258, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1283, 1284, 1285, 1286, 1288, 1257, 1289, 1290, 1291, 642, 818, 1292, 1293, 1295, 1297, 1298, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1310, 698, 1313, 1314, 1315, 1316, 1318, 1004, 731, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">122</infon><infon key="type">Disease</infon><location offset="133" length="17"/><text>Friedreich ataxia</text></annotation><annotation id="177977"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1231, 1232, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1258, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1273, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1288, 1257, 1289, 1290, 1291, 642, 818, 1292, 1293, 1294, 1295, 1297, 1298, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1310, 698, 1313, 1314, 1315, 1316, 1318, 1004, 731, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">124</infon><infon key="type">Disease</infon><location offset="153" length="4"/><text>FRDA</text></annotation><annotation id="177979"><infon key="annotator_ids">[874, 543, 565, 618, 703, 936, 1215, 1236, 1239, 751, 1254, 1258, 1276, 1279, 1285, 1291, 818, 750, 731, 637, 1098]</infon><infon key="n_annotators">21</infon><infon key="type">Disease</infon><location offset="164" length="32"/><text>severe neurodegenerative disease</text></annotation><annotation id="178714"><infon key="annotator_ids">[704, 838, 1035, 984, 678, 1224, 1088, 1231, 1234, 876, 1240, 385, 938, 1249, 194, 652, 1260, 914, 1265, 1270, 748, 1263, 752, 1278, 727, 1283, 1284, 1290, 1293, 1294, 1295, 1303, 1306, 1307, 1313, 1316, 1004]</infon><infon key="n_annotators">37</infon><infon key="type">Disease</infon><location offset="171" length="25"/><text>neurodegenerative disease</text></annotation><annotation id="177980"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 1226, 1227, 1228, 1230, 1231, 1232, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 751, 1251, 1252, 652, 1253, 1254, 1255, 1258, 1259, 152, 1260, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1273, 1275, 752, 1276, 1278, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1288, 1289, 1290, 1291, 642, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 698, 1313, 1314, 1315, 1316, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">120</infon><infon key="type">Disease</infon><location offset="545" length="4"/><text>FRDA</text></annotation><annotation id="177981"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1231, 1232, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1258, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1263, 1273, 1275, 752, 1276, 1278, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1302, 1306, 1307, 1310, 698, 1313, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">121</infon><infon key="type">Disease</infon><location offset="657" length="4"/><text>FRDA</text></annotation><annotation id="177984"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1232, 1218, 1234, 1235, 876, 1236, 813, 1239, 1240, 385, 1242, 1038, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1258, 1259, 152, 1260, 914, 1262, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1273, 1275, 752, 1276, 1278, 727, 766, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 642, 1292, 1293, 1294, 1295, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1306, 1307, 1308, 1310, 698, 1313, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">119</infon><infon key="type">Disease</infon><location offset="986" length="4"/><text>FRDA</text></annotation><annotation id="177985"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1230, 1232, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1258, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1273, 1275, 752, 1276, 1278, 727, 1280, 1282, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 642, 1292, 1293, 1294, 1295, 1297, 1298, 702, 1299, 1300, 750, 1304, 1303, 1306, 1307, 1308, 1310, 698, 1313, 1314, 1315, 1316, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">119</infon><infon key="type">Disease</infon><location offset="1043" length="4"/><text>FRDA</text></annotation><annotation id="177982"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1232, 1218, 1234, 1235, 876, 1236, 658, 813, 1239, 1240, 385, 1242, 1038, 938, 1245, 1246, 1061, 1250, 1249, 194, 751, 1251, 1252, 1253, 1254, 1255, 1258, 1259, 152, 1260, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1263, 1273, 1275, 752, 1276, 1278, 727, 766, 1280, 1282, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 1299, 1300, 750, 1304, 1303, 1302, 1306, 1307, 1308, 1310, 698, 1313, 1314, 1315, 1318, 1004, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">118</infon><infon key="type">Disease</infon><location offset="1273" length="4"/><text>FRDA</text></annotation></passage></document><document><id>10500204</id><infon key="annotator_ids">[1306, 752, 1270, 683, 1297, 642, 634, 18, 652, 936, 1088, 748, 1215, 727, 1223, 876]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia.  </text></passage><passage><infon key="type">abstract</infon><offset>85</offset><text>Friedreich ataxia ( FRDA ) , the most common of the inherited ataxias , is an autosomal recessive degenerative disorder , characterized clinically by onset before the age of 25 of progressive gait and limb ataxia , absence of deep tendon reflexes , extensor plantar responses , and loss of position and vibration sense in the lower limbs . FRDA is caused by a GAA triplet expansion in the first intron of the FRDA gene on chromosome 9q13 in 97 % of patients . The FRDA gene encodes a widely expressed 210-aa protein , frataxin , which is located in mitochondria and is severely reduced in FRDA patients . Frataxin function is still unknown but the knockout of the yeast frataxin homologue gene ( YFH1 ) showed a severe defect of mitochondrial respiration and loss of mtDNA associated with elevated intramitochondrial iron . Here we report in vivo evidence of impaired mitochondrial respiration in skeletal muscle of FRDA patients . Using phosphorus magnetic resonance spectroscopy we demonstrated a maximum rate of muscle mitochondrial ATP production ( V ( max ) ) below the normal range in all 12 FRDA patients and a strong negative correlation between mitochondrial V ( max ) and the number of GAA repeats in the smaller allele . Our results show that FRDA is a nuclear-encoded mitochondrial disorder affecting oxidative phosphorylation and give a rationale for treatments aimed to improve mitochondrial function in this condition . . </text><annotation id="183820"><infon key="annotator_ids">[1223, 634, 18, 1215, 1270, 876, 1088, 727, 652, 752, 642, 683, 748, 936, 1306, 1297]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="425" length="4"/><text>FRDA</text></annotation><annotation id="183823"><infon key="annotator_ids">[1223, 634, 18, 1215, 1270, 876, 1088, 727, 652, 752, 642, 683, 748, 936, 1306, 1297]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="674" length="4"/><text>FRDA</text></annotation><annotation id="183825"><infon key="annotator_ids">[1223, 634, 18, 1215, 1270, 876, 1088, 727, 652, 752, 642, 683, 748, 936, 1306, 1297]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1001" length="4"/><text>FRDA</text></annotation></passage></document><document><id>10636421</id><infon key="annotator_ids">[752, 1270, 1294, 18, 634, 1088, 1302, 1252, 748, 737, 727, 1236, 1223, 543, 876, 1279]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>X-linked retinoschisis with point mutations in the XLRS1 gene.  </text></passage><passage><infon key="type">abstract</infon><offset>64</offset><text>BACKGROUND  X-linked retinoschisis ( XLRS ) is a relatively rare vitreoretinal dystrophy that causes visual loss in young men . Recently , a gene responsible for this disease , designated XLRS1 , was identified , and several deleterious gene mutations were reported . OBJECTIVE  To analyze Japanese patients clinically diagnosed as having XLRS formutational changes in the XLRS1 gene . METHODS  Ten patients with XLRS underwent full ophthalmologic examination , including slitlamp biomicroscopy and dilated funduscopy . Genomic DNA was isolated from leukocytes , and all exons of the XLRS1 gene were amplified by polymerase chain reaction and analyzed using a direct sequencing method . RESULTS  Point mutations in the XLRS1 gene were identified in all 10 patients . The mutations were identical in each of 2 pairs of brothers . Six of the point mutations represented missense mutations , 1 was a nonsense mutation , and 1 was a frameshift mutation . Five of the mutations are newly reported herein . CONCLUSIONS  The discovery of new point mutations in this study increases the available information regarding the spectrum of genetic abnormalities and clinical manifestations of XLRS . However , the limited data failed to reveal a correlation between mutation and disease phenotype . CLINICAL RELEVANCE  Identification of mutations in the XLRS1 gene and expanded information on clinical manifestations will facilitate early diagnosis , appropriate early therapy , and genetic counseling regarding the prognosis of XLRS . . </text><annotation id="190543"><infon key="annotator_ids">[18, 634, 1236, 1252, 876, 737, 1279, 1223, 748, 1270, 543, 1294, 727, 1302, 752, 1088]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="403" length="4"/><text>XLRS</text></annotation><annotation id="190544"><infon key="annotator_ids">[18, 634, 1236, 1252, 876, 737, 1279, 1223, 748, 1270, 543, 1294, 727, 1302, 752, 1088]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="477" length="4"/><text>XLRS</text></annotation><annotation id="190546"><infon key="annotator_ids">[18, 634, 1236, 1252, 876, 737, 1279, 1223, 748, 1270, 543, 1294, 727, 1302, 752, 1088]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1580" length="4"/><text>XLRS</text></annotation></passage></document><document><id>8471773</id><infon key="annotator_ids">[1293, 752, 683, 1270, 1294, 838, 634, 936, 1088, 152, 748, 737, 727, 1223, 1236, 1224, 876, 1254]</infon><infon key="n_annotators">18</infon><passage><infon key="type">title</infon><offset>0</offset><text>Molecular characterization of glucose-6-phosphate dehydrogenase (G6PD) deficiency in patients of Chinese descent and identification of new base substitutions in the human G6PD gene.  </text></passage><passage><infon key="type">abstract</infon><offset>183</offset><text>The underlying DNA changes associated with glucose-6-phosphate dehydrogenase ( G6PD ) -deficient Asians have not been extensively investigated . To fill this gap , we sequenced the G6PD gene of 43 G6PD-deficient Chinese whose G6PD was well characterized biochemically . DNA samples were obtained from peripheral blood of these individuals for sequencing using a direct polymerase chain reaction ( PCR ) sequencing procedure . From these 43 samples , we have identified five different types of nucleotide substitutions in the G6PD gene  at cDNA 1388 from G to A ( Arg to His ) ; at cDNA 1376 from G to T ( Arg to Leu ) ; at cDNA 1024 from C to T ( Leu to Phe ) ; at cDNA 392 from G to T ( Gly to Val ) ; at cDNA 95 from A to G ( His to Arg ) . These five nucleotide substitutions account for over 83 % of our 43 G6PD-deficient samples and these substitutions have not been reported in non-Asians . The substitutions found at cDNA 392 and cDNA 1024 are new findings . The substitutions at cDNA 1376 and 1388 account for over 50 % of the 43 samples examined indicating a high prevalence of these two alleles among G6PD-deficient Chinese . Our findings add support to the notion that diverse point mutations may account largely for much of the phenotypic heterogeneity of G6PD deficiency . . </text><annotation id="179528"><infon key="annotator_ids">[634, 683, 1223, 1236, 838, 748, 1254, 1088, 1270, 737, 1293, 1224, 752, 152, 1294, 876, 727, 936]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="1294" length="14"/><text>G6PD-deficient</text></annotation><annotation id="179529"><infon key="annotator_ids">[634, 683, 1223, 1236, 838, 748, 1254, 1088, 1270, 737, 1293, 1224, 752, 152, 1294, 876, 727, 936]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="1451" length="15"/><text>G6PD deficiency</text></annotation></passage></document><document><id>8530105</id><infon key="annotator_ids">[683, 1297, 1294, 642, 838, 652, 18, 634, 936, 1038, 152, 737, 727, 1224, 385, 876, 1254, 1267]</infon><infon key="n_annotators">18</infon><passage><infon key="type">title</infon><offset>0</offset><text>A 4-megabase YAC contig that spans the Langer-Giedion syndrome region on human chromosome 8q24.1: use in refining the location of the trichorhinophalangeal syndrome and multiple exostoses genes (TRPS1 and EXT1).  </text><annotation id="185635"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 1267, 838, 1297, 876, 1294, 152, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="39" length="23"/><text>Langer-Giedion syndrome</text></annotation><annotation id="185636"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 1267, 838, 1297, 876, 1294, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="134" length="30"/><text>trichorhinophalangeal syndrome</text></annotation></passage><passage><infon key="type">abstract</infon><offset>213</offset><text>We have constructed a physical map covering over 4 Mb of human chromosome 8q24 . 1 and used this map to refine the locations of the genes responsible for Langer-Giedion syndrome . The map is composed of overlapping YAC clones that were identified and ordered in relation to sequence tagged sites mapped to the Langer-Giedion chromosomal region on somatic cell hybrids . The minimal region of overlap of Langer-Giedion syndrome deletions , previously identified by analysis of 15 patients , was placed on the map by analysis of 2 patients whose deletions define the endpoints . The chromosome 8 breakpoint of a balanced t ( 8 ; 9 ) ( q24 . 11 ; q33 . 3 ) translocation from a patient with trichorhinophalangeal syndrome ( TRPS I ) was found to be located just within the proximal end of the minimal deletion region . A deletion of 8q24 . 11-q24 11-q24 . 3 in a patient with multiple exostoses was found to overlap the distal end of the LGS deletion region , indicating that the EXT1 gene is distal to the TRPS1 gene and supporting the hypothesis that Langer-Giedion syndrome is due to loss of functional copies of both the TRPS1 and the EXT1 genes </text><annotation id="185637"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 385, 1267, 838, 1297, 876, 1294, 152, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="367" length="23"/><text>Langer-Giedion syndrome</text></annotation><annotation id="185638"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 385, 1267, 838, 1297, 876, 1294, 152, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="616" length="23"/><text>Langer-Giedion syndrome</text></annotation><annotation id="185639"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 385, 1267, 838, 1297, 876, 1294, 152, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="901" length="30"/><text>trichorhinophalangeal syndrome</text></annotation><annotation id="185642"><infon key="annotator_ids">[1224, 1038, 18, 634, 1254, 737, 385, 1267, 838, 1297, 876, 1294, 152, 727, 683, 652, 936, 642]</infon><infon key="n_annotators">18</infon><infon key="type">Disease</infon><location offset="1263" length="23"/><text>Langer-Giedion syndrome</text></annotation></passage></document><document><id>10417279</id><infon key="annotator_ids">[678, 1270, 1294, 838, 18, 634, 652, 1088, 936, 1245, 727, 1223, 1224, 1213, 876, 518]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. The Clinical European Network on Brain Dysmyelinating Disease.  </text></passage><passage><infon key="type">abstract</infon><offset>275</offset><text>Pelizaeus-Merzbacher Disease ( PMD ) is an X-linked developmental defect of myelination affecting the central nervous system and segregating with the proteolipoprotein ( PLP ) locus . Investigating 82 strictly selected sporadic cases of PMD , we found PLP mutations in 77 % ; complete PLP-gene duplications were the most frequent abnormality ( 62 % ) , whereas point mutations in coding or splice-site regions of the gene were involved less frequently ( 38 % ) . We analyzed the maternal status of 56 cases to determine the origin of both types of PLP mutation , since this is relevant to genetic counseling . In the 22 point mutations , 68 % of mothers were heterozygous for the mutation , a value identical to the two-thirds of carrier mothers that would be expected if there were an equal mutation rate in male and female germ cells . In sharp contrast , among the 34 duplicated cases , 91 % of mothers were carriers , a value significantly ( chi2 = 9 . 20 , P &lt; . 01 ) in favor of a male bias , with an estimation of the male / female mutation frequency ( k ) of 9 . 3 3 . Moreover , we observed the occurrence of de novo mutations between parental and grandparental generations in 17 three-generation families , which allowed a direct estimation of the k value ( k = 11 ) . Again , a significant male mutation imbalance was observed only for the duplications . </text><annotation id="182345"><infon key="annotator_ids">[678, 876, 1245, 838, 518, 1224, 936, 18, 1270, 634, 652, 1294, 1223, 727, 1088, 1213]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="275" length="28"/><text>Pelizaeus-Merzbacher Disease</text></annotation><annotation id="182346"><infon key="annotator_ids">[678, 876, 1245, 838, 518, 1224, 936, 18, 1270, 634, 652, 1294, 1223, 727, 1088, 1213]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="306" length="3"/><text>PMD</text></annotation></passage></document><document><id>10480214</id><infon key="annotator_ids">[748, 1306, 752, 727, 1270, 1297, 818, 838, 876, 18, 634, 1088, 936, 1218, 1310, 1304]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>Early onset of X-linked Emery-Dreifuss muscular dystrophy in a boy with emerin gene deletion.  </text></passage><passage><infon key="type">abstract</infon><offset>95</offset><text>A boy developed contractures of the Achilles tendons at 3 years and of the postcervical muscles at 7 years , although neither contractures of the elbows nor cardiac abnormality were recognized by the age of 9 years . Muscle computed tomography scanning revealed changes characteristic of muscle involvement . Emerin was not detected in the biopsied muscle , and RT-PCR and PCR-based genomic DNA analyses of the emerin gene demonstrated no amplification product in the patient . These results confirmed the diagnosis of X-linked Emery-Dreifuss muscular dystrophy ( EDMD ) , and reinforce the necessity of molecular genetic diagnosis of the membrane protein emerin in younger patients with possible EDMD before appearance of the typical symptoms , to avoid sudden cardiac death . . </text><annotation id="188004"><infon key="annotator_ids">[838, 634, 1270, 1218, 1297, 752, 936, 1088, 727, 18, 876, 818, 1306, 1304, 748, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="659" length="4"/><text>EDMD</text></annotation><annotation id="188005"><infon key="annotator_ids">[838, 634, 1270, 1218, 1297, 752, 936, 1088, 727, 18, 876, 818, 1306, 1304, 748, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="792" length="4"/><text>EDMD</text></annotation></passage></document><document><id>10353787</id><infon key="annotator_ids">[1306, 752, 683, 1270, 1297, 1260, 1231, 652, 634, 18, 1088, 936, 1061, 727, 1236, 1223, 1269]</infon><infon key="n_annotators">17</infon><passage><infon key="type">title</infon><offset>0</offset><text>Overgrowth of oral mucosa and facial skin, a novel feature of aspartylglucosaminuria.  </text><annotation id="179876"><infon key="annotator_ids">[936, 1231, 1061, 683, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1260, 1088, 1306, 752]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="62" length="22"/><text>aspartylglucosaminuria</text></annotation></passage><passage><infon key="type">abstract</infon><offset>87</offset><text>Aspartylglucosaminuria ( AGU ) is a lysosomal storage disorder caused by deficiency of aspartylglucosaminidase ( AGA ) . The main symptom is progressive mental retardation . A spectrum of different mutations has been reported in this disease , one missense mutation ( Cys163Ser ) being responsible for the majority of Finnish cases . We were able to examine 66 Finnish AGU patients for changes in the oral mucosa and 44 of these for changes in facial skin . Biopsy specimens of 16 oral lesions , 12 of them associated with the teeth , plus two facial lesions were studied histologically . Immunohistochemical staining for AGA was performed on 15 oral specimens . Skin was seborrhoeic in adolescent and adult patients , with erythema of the facial skin already common in childhood . Of 44 patients , nine ( 20 % ) had facial angiofibromas , tumours primarily occurring in association with tuberous sclerosis . Oedemic buccal mucosa ( leucoedema ) and gingival overgrowths were more frequent in AGU patients than in controls ( p &lt; 0 . 001 ) . Of 16 oral mucosal lesions studied histologically , 15 represented fibroepithelial or epithelial hyperplasias and were reactive in nature . Cytoplasmic vacuolisation was evident in four . Immunohistochemically , expression of AGA in AGU patients mucosal lesions did not differ from that seen in corresponding lesions of normal subjects . Thus , the high frequency of mucosal overgrowth in AGU patients does not appear to be directly associated with lysosomal storage or with alterations in the level of AGA expression . </text><annotation id="179877"><infon key="annotator_ids">[936, 1231, 1061, 683, 652, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1260, 1088, 1306, 752]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="87" length="22"/><text>Aspartylglucosaminuria</text></annotation><annotation id="179878"><infon key="annotator_ids">[936, 1231, 1061, 683, 652, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1260, 1088, 1306, 752]</infon><infon key="n_annotators">17</infon><infon key="type">Disease</infon><location offset="112" length="3"/><text>AGU</text></annotation><annotation id="179889"><infon key="annotator_ids">[936, 1231, 1061, 683, 652, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1088, 1306, 752]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="975" length="18"/><text>tuberous sclerosis</text></annotation><annotation id="179897"><infon key="annotator_ids">[936, 1231, 1061, 683, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1260, 1088, 1306, 752]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1361" length="3"/><text>AGU</text></annotation><annotation id="179901"><infon key="annotator_ids">[936, 1231, 1061, 683, 1236, 634, 1269, 18, 1223, 1270, 727, 1297, 1260, 1088, 1306, 752]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="1517" length="3"/><text>AGU</text></annotation></passage></document><document><id>7759075</id><infon key="annotator_ids">[1292, 1293, 1004, 1290, 1291, 683, 1296, 1319, 1297, 1318, 1294, 1295, 1316, 1315, 1314, 1313, 1310, 1098, 152, 748, 1289, 1288, 1287, 678, 1280, 1282, 1283, 1284, 1285, 1286, 1321, 1088, 936, 1320, 938, 737, 543, 1276, 876, 1279, 874, 1278, 731, 1275, 1273, 1270, 1271, 18, 727, 518, 1269, 1267, 1265, 1261, 1307, 1262, 1306, 1309, 813, 1263, 1308, 698, 1260, 818, 914, 1301, 1300, 1303, 1061, 1302, 1304, 716, 993, 1259, 1258, 1255, 618, 1254, 1257, 1256, 642, 194, 1253, 1252, 1251, 984, 1250, 1245, 1246, 1243, 1249, 385, 703, 704, 702, 637, 838, 1035, 633, 634, 1240, 501, 1038, 1242, 1232, 1234, 1235, 1236, 1237, 1239, 766, 1231, 1230, 1227, 1228, 1225, 1226, 1223, 1224, 1221, 1222, 959, 752, 658, 750, 751, 1298, 1299, 652, 1220, 1215, 1216, 1217, 1210, 1211, 1213, 565, 1218]</infon><infon key="n_annotators">138</infon><passage><infon key="type">title</infon><offset>0</offset><text>Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer.  </text><annotation id="177968"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 1211, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1224, 1088, 1225, 993, 1226, 1227, 1231, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1240, 1242, 1038, 1245, 1061, 1249, 1250, 194, 751, 1252, 1253, 1254, 1256, 1257, 1258, 152, 914, 1262, 1263, 518, 1265, 1267, 1269, 1261, 737, 748, 1271, 1273, 752, 1278, 727, 1280, 1283, 1285, 1290, 1291, 818, 1292, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1301, 1302, 1304, 1306, 633, 1307, 1308, 1310, 698, 959, 1313, 1314, 1315, 1318, 1004, 731, 716, 1321, 1098]</infon><infon key="n_annotators">107</infon><infon key="type">Disease</infon><location offset="73" length="22"/><text>familial breast cancer</text></annotation></passage><passage><infon key="type">abstract</infon><offset>98</offset><text>We searched for criteria that could indicate breast cancer families with a high prior probability of being caused by the breast / ovarian cancer susceptibility locus BRCA1 on chromosome 17 . To this end , we performed a linkage study with 59 consecutively collected Dutch breast cancer families , including 16 with at least one case of ovarian cancer . We used an intake cut-off of at least three first-degree relatives with breast and / or ovarian cancer at any age . Significant evidence for linkage was found only among the 13 breast cancer families with a mean age at diagnosis of less than 45 years . An unexpectedly low proportion of the breast-ovarian cancer families were estimated to be linked to BRCA1 , which could be due to a founder effect in the Dutch population . Given the expected logistical problems in clinical management now that BRCA1 has been identified , we propose an interim period in which only families with a strong positive family history for early onset breast and / or ovarian cancer will be offered BRCA1 mutation testing . . </text><annotation id="177969"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 1211, 501, 1213, 1215, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 642, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1302, 1304, 1303, 1306, 1308, 1310, 698, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">127</infon><infon key="type">Disease</infon><location offset="143" length="13"/><text>breast cancer</text></annotation><annotation id="178100"><infon key="annotator_ids">[543, 634, 1210, 704, 618, 838, 703, 936, 1211, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1228, 1231, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 702, 1299, 750, 1301, 1304, 1303, 1306, 1307, 1308, 1309, 1310, 698, 1313, 1314, 1315, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">124</infon><infon key="type">Disease</infon><location offset="219" length="23"/><text>breast / ovarian cancer</text></annotation><annotation id="177973"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 993, 1226, 1227, 1232, 1218, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1038, 1245, 1246, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1259, 152, 1260, 914, 1262, 518, 1265, 1267, 1269, 1270, 1261, 737, 1271, 1275, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1291, 642, 818, 1292, 1293, 1294, 1295, 1297, 1298, 1299, 1300, 750, 1302, 1304, 1303, 1306, 1308, 1310, 698, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 1320, 1321, 1098]</infon><infon key="n_annotators">114</infon><infon key="type">Disease</infon><location offset="370" length="13"/><text>breast cancer</text></annotation><annotation id="177972"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 1211, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1231, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1243, 1038, 1245, 1246, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 642, 818, 1292, 1293, 1294, 1295, 1297, 1298, 702, 1299, 1300, 750, 1301, 1302, 1304, 1303, 1306, 633, 1307, 1308, 1310, 698, 959, 1313, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1098]</infon><infon key="n_annotators">131</infon><infon key="type">Disease</infon><location offset="434" length="14"/><text>ovarian cancer</text></annotation><annotation id="177971"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 703, 936, 1211, 501, 1213, 1215, 1216, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1243, 1038, 1246, 1061, 1249, 1250, 194, 1251, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1276, 1278, 1279, 727, 1280, 1282, 1284, 1285, 1286, 1287, 1288, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1301, 1302, 1304, 1303, 1306, 633, 1307, 1308, 1310, 698, 959, 1313, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">126</infon><infon key="type">Disease</infon><location offset="523" length="30"/><text>breast and / or ovarian cancer</text></annotation><annotation id="177970"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 1211, 501, 1213, 1215, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1246, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 737, 748, 1271, 1273, 1275, 752, 1278, 1279, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 1300, 750, 1302, 1304, 1303, 1306, 1308, 1310, 698, 959, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">127</infon><infon key="type">Disease</infon><location offset="628" length="13"/><text>breast cancer</text></annotation><annotation id="177975"><infon key="annotator_ids">[874, 543, 565, 634, 1210, 704, 618, 838, 936, 501, 1213, 1215, 1217, 1035, 683, 18, 1220, 984, 678, 1221, 1222, 1223, 1224, 1088, 1225, 993, 1226, 1227, 1228, 1230, 1232, 1218, 938, 1234, 1235, 876, 1236, 1237, 658, 813, 1239, 1240, 385, 1242, 1243, 1038, 1245, 1061, 1249, 1250, 194, 751, 1251, 1252, 652, 1253, 1254, 1255, 1256, 1257, 1258, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1267, 1269, 1270, 1261, 748, 1271, 1275, 752, 1276, 1278, 1279, 727, 766, 1280, 1282, 1283, 1284, 1285, 1286, 1287, 1288, 1289, 1290, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1297, 1298, 702, 1299, 750, 1302, 1304, 1303, 1306, 1308, 1309, 1310, 698, 959, 1314, 1315, 1316, 1318, 1004, 731, 1319, 637, 716, 1320, 1321, 1098]</infon><infon key="n_annotators">125</infon><infon key="type">Disease</infon><location offset="742" length="21"/><text>breast-ovarian cancer</text></annotation><annotation id="177974"><infon key="annotator_ids">[874, 543, 618, 838, 703, 936, 1211, 1213, 1035, 683, 984, 1221, 1088, 1218, 1237, 658, 1240, 385, 1242, 1243, 1038, 1249, 1253, 1255, 1258, 1267, 1269, 1261, 748, 1273, 1275, 1276, 1278, 727, 1280, 1283, 1285, 1287, 1291, 818, 1292, 1293, 1294, 1295, 1296, 1301, 1302, 1304, 1306, 633, 1307, 1308, 1310, 698, 959, 1313, 716, 1098]</infon><infon key="n_annotators">58</infon><infon key="type">Disease</infon><location offset="1070" length="42"/><text>early onset breast and / or ovarian cancer</text></annotation><annotation id="178196"><infon key="annotator_ids">[565, 634, 1210, 704, 501, 1215, 1217, 18, 1220, 678, 1223, 1224, 1225, 993, 1226, 1230, 1232, 938, 1234, 1235, 1236, 813, 1239, 1245, 1246, 1061, 1250, 194, 1251, 1252, 652, 1254, 1256, 1257, 1259, 152, 1260, 914, 1262, 1263, 518, 1265, 1270, 737, 1271, 1275, 752, 1279, 1282, 1284, 1286, 1288, 1290, 1297, 1298, 702, 1300, 750, 1309, 1314, 1316, 1318, 731, 1319, 637, 1320, 1321]</infon><infon key="n_annotators">67</infon><infon key="type">Disease</infon><location offset="1082" length="30"/><text>breast and / or ovarian cancer</text></annotation></passage></document><document><id>7444053</id><infon key="annotator_ids">[752, 1297, 838, 18, 652, 634, 1220, 1088, 936, 1310, 1216, 1225, 1235, 1226, 876, 1218]</infon><infon key="n_annotators">16</infon><passage><infon key="type">title</infon><offset>0</offset><text>A new CT pattern in adrenoleukodystrophy.  </text></passage><passage><infon key="type">abstract</infon><offset>43</offset><text>A new CT pattern was observed in 2 patients with adrenoleukodystrophy ( ALD ) . This pattern , which the authors call Type II , is characterized by the absence of posterior periventricular areas of decreased attenuation around the trigone on non-contrast scans  after contrast infusion , however , there is striking enhancement of various white-matter structures ( tracts or fiber systems ) such as the internal capsules , corpus callosum , corona radiata , forceps major , and cerebral peduncles . This is different from numerous previous descriptions of the CT pattern in ALD . Type II ALD does not appear to have been seen in any other leukoencephalopathy and is probably specific for a phenotypic variant or an evolving stage of ALD . . </text><annotation id="180714"><infon key="annotator_ids">[1216, 18, 838, 1225, 1235, 936, 1220, 652, 1226, 634, 876, 1218, 1088, 1297, 752, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="92" length="20"/><text>adrenoleukodystrophy</text></annotation><annotation id="180715"><infon key="annotator_ids">[1216, 18, 838, 1225, 1235, 936, 1220, 652, 1226, 634, 876, 1218, 1088, 1297, 752, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="115" length="3"/><text>ALD</text></annotation><annotation id="180717"><infon key="annotator_ids">[1216, 18, 838, 1225, 1235, 936, 1220, 652, 1226, 634, 876, 1218, 1088, 1297, 752, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="617" length="3"/><text>ALD</text></annotation><annotation id="180720"><infon key="annotator_ids">[1216, 18, 838, 1225, 1235, 936, 1220, 652, 1226, 634, 876, 1218, 1088, 1297, 752, 1310]</infon><infon key="n_annotators">16</infon><infon key="type">Disease</infon><location offset="776" length="3"/><text>ALD</text></annotation></passage></document></collection>